S2Medical AB (publ) (STO:S2M)
0.0099
+0.0002 (2.06%)
At close: Mar 4, 2026
S2Medical AB Market Cap
S2Medical AB has a market cap or net worth of 8.98 million as of March 4, 2026. Its market cap has increased by 6.33% in one year.
Market Cap
8.98M
Enterprise Value
8.07M
Revenue
16.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since November 28, 2018, S2Medical AB's market cap has decreased from 214.61M to 8.98M, a decrease of -95.82%. That is a compound annual growth rate of -35.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 8.80M | -2.63% |
| Dec 30, 2025 | 9.03M | 1.90% |
| Dec 30, 2024 | 8.86M | -46.36% |
| Dec 29, 2023 | 16.53M | -25.20% |
| Dec 30, 2022 | 22.09M | -72.04% |
| Dec 30, 2021 | 79.02M | -12.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 136.67B |
| Getinge AB | 55.26B |
| Sectra AB | 37.34B |
| Medicover AB | 32.84B |
| Perpetua Medical AB | 18.00M |
| Fluicell AB | 18.00M |
| Gabather AB | 17.70M |
| Aptahem AB | 16.82M |